Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
Wednesday, May 31, 2023
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Facebook
Twitter
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
Home
Regulatory Affairs
Regulatory Affairs
Regulatory Affairs
Drug Approval Process in China
admin
-
January 19, 2020
Regulatory Affairs
Approval pathways of Fixed dose combination (FDC) in India
admin
-
January 12, 2020
Regulatory Affairs
Drug Approval Process in India
admin
-
January 4, 2020
Regulatory Affairs
Orphan Drug Designation in US, EU and Japan
admin
-
December 31, 2019
Regulatory Affairs
The Drug approval process in EU:
admin
-
December 29, 2019
Regulatory Affairs
Biologics Approval Pathways in the USA:
admin
-
December 27, 2019
0
Regulatory Affairs
Generic Products Approval Pathways (USA): Paragraph Certification I, II, III, and IV:
admin
-
December 25, 2019
0
Regulatory Affairs
Drug Approval process-FDA
admin
-
December 21, 2019
2
Regulatory Affairs
Medical Device Registration in Japan-Todokede, Ninsho and Shonin Pathways
admin
-
November 23, 2019
0
- Advertisment -
Most Read
FDA Approves First Drug to Treat Agitation Symptoms Associated with Dementia due to Alzheimer’s Disease
May 17, 2023
FDA Approves Novel Drug to Treat Moderate to Severe Hot Flashes Caused by Menopause
May 17, 2023
Farxiga extended in US to reduce risk of cardiovascular death and hospitalisation for heart failure to a broader range of patients
May 9, 2023
BMS Receives EC Approval for CAR T Cell Therapy Breyanzi for Relapsed or Refractory Large B-cell Lymphoma After One Prior Therapy
May 8, 2023